Top Markets
#1 Black Phoenix Black Phoenix +166.52%
#2 Islamic Coin Islamic Coin +158.25%
#3 Glidr Glidr +84.34%
#4 Test Test +21.69%
#5 Cryptopia Cryptopia +21.17%
#6 Quantum Resistant Ledger Quantum Resistant Ledger +18.52%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.45%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +12.47%
#9 MarsCoin MarsCoin +11.59%
#10 DOVU DOVU +8.82%
Coin of the day
Black Phoenix Black Phoenix
設定
言語
日本
通貨
USD
テーマ
RenovaCare, Inc. RenovaCare, Inc.

RenovaCare, Inc.

RCAR
株式のランク #41860
RenovaCare, Inc., a development-stage biotech and medical device company,... RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name RenovaCare, Inc.,to RenovaCare, Inc. in January 2014. RenovaCare, Inc. was incorporated in 1983 and is based in Scottsdale, Arizona.
株価
$0.0001
最終同期: 2026-08-11
時価総額
$8.74K
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 RenovaCare, Inc. (RCAR)

カテゴリー

Healthcare
RenovaCare, Inc.（RCAR）の収益
Aug 2026 時点の収益 TTM: 0
RenovaCare, Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
RenovaCare, Inc. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR